©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2484-2495
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2484
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2484
Table 6 Maintenance therapy in Crohn's disease following induction of remission or response
| Induction therapy | Maintenance therapy | ||||
| Subjects | Regimen | Regimen | Duration | ||
| 1 yr | 2 yr | ||||
| Candy et al[55], 1995 | CDAI > 200 | PS (diminishing dose) + AZA 12 wk | AZA 2.5 mg/kg | Remission rate 42% (14/33) | |
| Placebo | 7% (2/30) | ||||
| Hanauer et al[56], 2002 | CDAI ≥ 220 | Gr (1) and Gr (2) | Gr (1) INFX 5 mg/kg every 8 wk | Remission rate 25% (28/113) | |
| Responder to a single infusion of infliximab | INFX 5 mg/kg at weeks 0, 2, 6 | Gr (2) INFX 10 mg/kg every 8 wk | 33% (37/112) | ||
| Gr (3) INFX 5 mg/kg then placebo infusion at weeks 2, 6 | Gr (3) placebo infusion every 8 wk | 11% (12/110) | |||
| Sandborn et al[58], 2005 | Mild to moderate CD | Budesonide 6 mg or 3 mg | Budesonide 6 mg or 3 mg | Relapse rate 60%-70% | |
| Placebo | (In all 3 groups) | ||||
| Takagi et al[39], 2006 | Active CD | TPN (25 cases), TEN (22 cases), | ED (half) + a free diet (half) | Relapse rate 26.9% (7/26) | |
| PS (1 case), INFX (3 cases) | A free diet | 64.0% (16/25) | |||
| Regueiro et al[59], 2009 | CD patients who had surgery | Ileocolonic resection | INFX 5 mg/kg at weeks 0, 2, 6 | Remission rate 80% (8/10) | |
| then every 8 wk | |||||
| Placebo | 58% (7/13) | ||||
| Present study | Active CD | INFX 5 mg/kg at weeks 0, 2, 6 (16 cases), intestinal resection (5 cases), SSZ (1 case) | Semi-vegetarian diet | Remission rate 100% (16/16) | 92% |
| Omnivorous diet | 67% (4/6) | 25% | |||
- Citation: Chiba M, Abe T, Tsuda H, Sugawara T, Tsuda S, Tozawa H, Fujiwara K, Imai H. Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet. World J Gastroenterol 2010; 16(20): 2484-2495
- URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2484.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i20.2484